1. Home
  2. BOXL vs ONCT Comparison

BOXL vs ONCT Comparison

Compare BOXL & ONCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOXL
  • ONCT
  • Stock Information
  • Founded
  • BOXL 1985
  • ONCT N/A
  • Country
  • BOXL United States
  • ONCT United States
  • Employees
  • BOXL N/A
  • ONCT N/A
  • Industry
  • BOXL Telecommunications Equipment
  • ONCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOXL Telecommunications
  • ONCT Health Care
  • Exchange
  • BOXL Nasdaq
  • ONCT Nasdaq
  • Market Cap
  • BOXL 4.0M
  • ONCT 4.3M
  • IPO Year
  • BOXL 2017
  • ONCT N/A
  • Fundamental
  • Price
  • BOXL $0.41
  • ONCT $1.13
  • Analyst Decision
  • BOXL Buy
  • ONCT Buy
  • Analyst Count
  • BOXL 2
  • ONCT 3
  • Target Price
  • BOXL $1.00
  • ONCT $10.00
  • AVG Volume (30 Days)
  • BOXL 97.8K
  • ONCT 157.5K
  • Earning Date
  • BOXL 11-13-2024
  • ONCT 11-06-2024
  • Dividend Yield
  • BOXL N/A
  • ONCT N/A
  • EPS Growth
  • BOXL N/A
  • ONCT N/A
  • EPS
  • BOXL N/A
  • ONCT N/A
  • Revenue
  • BOXL $150,709,000.00
  • ONCT $2,161,000.00
  • Revenue This Year
  • BOXL N/A
  • ONCT $113.76
  • Revenue Next Year
  • BOXL $6.20
  • ONCT N/A
  • P/E Ratio
  • BOXL N/A
  • ONCT N/A
  • Revenue Growth
  • BOXL N/A
  • ONCT 227.92
  • 52 Week Low
  • BOXL $0.41
  • ONCT $1.03
  • 52 Week High
  • BOXL $1.13
  • ONCT $13.20
  • Technical
  • Relative Strength Index (RSI)
  • BOXL 35.70
  • ONCT 37.09
  • Support Level
  • BOXL $0.44
  • ONCT $1.03
  • Resistance Level
  • BOXL $0.56
  • ONCT $1.30
  • Average True Range (ATR)
  • BOXL 0.05
  • ONCT 0.19
  • MACD
  • BOXL -0.00
  • ONCT -0.01
  • Stochastic Oscillator
  • BOXL 2.94
  • ONCT 13.70

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

About ONCT Oncternal Therapeutics Inc.

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoprotein. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that target ROR1, and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The Company has one operating segment in the United States.

Share on Social Networks: